regrafted with thin split-thickness skin graft
ProcedureGroup A (the treatment group) were regrafted with thin split-thickness skin graft
NCT Number: NCT01974583
Split-thickness skin grafting remains fundamental treatment of patients with deep burns and other traumatic injuries. However, the split-thickness skin graft (STSG) donor site dressing has been controversial until now. Our study here aimed to assess patient comfort and wound-healing efficacy with the application of thin split-thickness grafting on STSG donor sites.
Looking for future studies?
Notify Me5 year–56 year
All sexes
Observational
Background:Split-thickness skin grafting remains fundamental treatment of patients with deep burns and other traumatic injuries. However, the split-thickness skin graft (STSG) donor site dressing has been controversial until now. Our study here aimed to assess patient comfort and wound-healing efficacy with the application of thin split-thickness grafting on STSG donor sites.
Methods: 192 consecutive patients undergoing split-thickness skin grafting were included in the study and the participants were randomly divided into three groups: Group A was regrafted with thin STSG, while, Group B and Group C were covered with the occlusive hydrocellular dressing and paraffin gauze, respectively. The three groups were compared regarding to the time of epithelialization, pain sensed by the patients and the scar formation.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Group A (the treatment group) were regrafted with thin split-thickness skin graft
group B covered with the occlusive hydrocellular dressing (Allevyn Adhesive, Smith & Nephew)
Group C covered with paraffin gauze
Time frame: up to 4 weeks
The time of epithelialization was observed every 3 days
Time frame: up to 6 months
Pain sensed by the patients was assessed by Wong-Baker FACES Pain Rating Scale on day 2 and 5 after surgery
Time frame: 1 year
Scar formation of skin donor sites was evaluated by Vancouver scar scale in terms of colour, vascular distribution, thickness and scratchability 6-12 months after surgery
Tang-Du Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04050124
Donor Site Complication, Skin Graft Disorder
New York, United States
View Trial DetailsNCT02799290
Wound Healing Disturbance of
Tampere, Pirkanmaa, Finland
View Trial DetailsNCT01986959
Neurologic Manifestations, Pain
Santa Maria, Rio Grande do Sul, Brazil
View Trial DetailsNCT06275776
Wound Healing Disturbance of
Zoetermeer, South Holland, Netherlands
View Trial Details